Bradley Foster & Sargent Inc. CT Increases Holdings in Intuitive Surgical, Inc. $ISRG

Bradley Foster & Sargent Inc. CT increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.7% in the 1st quarter, HoldingsChannel.com reports. The firm owned 50,697 shares of the medical equipment provider’s stock after acquiring an additional 1,797 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in Intuitive Surgical were worth $23,371,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Lombard Odier Asset Management Switzerland SA lifted its holdings in Intuitive Surgical by 6.0% in the 1st quarter. Lombard Odier Asset Management Switzerland SA now owns 18,327 shares of the medical equipment provider’s stock worth $8,449,000 after purchasing an additional 1,040 shares in the last quarter. Lombard Odier Asset Management USA Corp purchased a new stake in Intuitive Surgical during the 1st quarter valued at approximately $203,000. Unio Capital LLC raised its position in shares of Intuitive Surgical by 14.4% during the first quarter. Unio Capital LLC now owns 66,238 shares of the medical equipment provider’s stock valued at $30,535,000 after buying an additional 8,320 shares during the last quarter. Wealth Alliance LLC raised its position in shares of Intuitive Surgical by 5.9% during the first quarter. Wealth Alliance LLC now owns 2,961 shares of the medical equipment provider’s stock valued at $1,365,000 after buying an additional 166 shares during the last quarter. Finally, Unisphere Establishment purchased a new position in shares of Intuitive Surgical in the first quarter worth $2,121,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical unveiled a five-layer AI framework for its surgical platforms and demonstrated live telesurgical collaboration, signaling that it is embedding AI into clinical workflows and expanding the capabilities of its robotic surgery ecosystem. Intuitive Surgical (ISRG) Unveils Five Layer AI Plan And Live Telesurgery Demo
• Positive Sentiment: Several analyst-focused pieces framed ISRG as a strong long-term MedTech growth name, highlighting its innovation pipeline, recurring revenue, and high switching costs for surgeons. Why Intuitive Surgical, Inc. (ISRG) is a Top Growth Stock for the Long-Term
• Positive Sentiment: Coverage around Wall Street recommendations continued to describe Intuitive Surgical as a favored investment idea, supporting sentiment around the company’s durable business model. Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?
• Positive Sentiment: CONMED’s expanded AirSeal indication for da Vinci 5 compatibility may help broaden use across Intuitive Surgical’s platform, reinforcing the ecosystem around its robotic systems. CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula
• Neutral Sentiment: Intuitive Surgical remains a frequent subject of analyst and stock-report coverage, but these pieces are mostly commentary rather than new fundamentals, so they are unlikely to move the stock on their own. Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors
• Neutral Sentiment: Short-interest data showed no meaningful change in reported shares, offering little direct signal for investors.
• Negative Sentiment: Some articles emphasized that ISRG’s shares have pulled back sharply and questioned whether growth expectations in its biggest market are changing, which can weigh on sentiment. Intuitive Surgical Stock Is On Sale, But Is the Growth Story Changing?
• Negative Sentiment: J&J’s progress on Ottava was viewed as a reminder that competition in robotic surgery is intensifying, adding pressure to Intuitive Surgical’s market leadership narrative. J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.

Analyst Ratings Changes

Several research firms recently weighed in on ISRG. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Truist Financial decreased their price target on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. The Goldman Sachs Group set a $558.00 price objective on Intuitive Surgical in a research report on Wednesday, May 27th. Bank of America reduced their target price on Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Twenty-one analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $523.46.

Intuitive Surgical Stock Up 1.7%

ISRG stock opened at $337.50 on Friday. The company has a fifty day simple moving average of $406.88 and a two-hundred day simple moving average of $459.98. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The firm has a market capitalization of $119.23 billion, a P/E ratio of 38.66, a price-to-earnings-growth ratio of 2.44 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business’s revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.81 EPS. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total transaction of $236,730.00. Following the transaction, the director owned 239 shares of the company’s stock, valued at approximately $113,156.94. The trade was a 67.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president owned 5,720 shares in the company, valued at $2,426,080.80. The trade was a 6.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.